Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
- Resource Type
- Academic Journal
- Authors
- Hughes, T P; Leber, B; Cervantes, F; Spector, N; Pasquini, R; Clementino, N CD; Schwarer, A P; Dorlhiac-Llacer, P E; Mahon, F-X; Rea, D; Guerci-Bresler, A; Kamel-Reid, S; Bendit, I; Acharya, S; Glynos, T; Dalal, D; Branford, S; Lipton, J H
- Source
- Leukemia. Nov 01, 2017 31(11):2529-2531
- Subject
- Language
- English
- ISSN
- 0887-6924